Beijing Ruiweixituo Biotechnology Co.,Ltd. – Trademark Portfolio

Entity Type: 99

Beijing Ruiweixituo Biotechnology Co.,Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include HERBA MEGA. The owner is based in Beijing.

4012, 4F, Building 8, Weibohao Garden, No.1, Weigongcun Street, Haidian District,

Beijing 100080 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Beijing Ruiweixituo Biotechnology Co.,Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Beijing Ruiweixituo Biotechnology Co.,Ltd. have?

Beijing Ruiweixituo Biotechnology Co.,Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Beijing Ruiweixituo Biotechnology Co.,Ltd. file in?

Beijing Ruiweixituo Biotechnology Co.,Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Beijing Ruiweixituo Biotechnology Co.,Ltd.'s most well-known trademarks?

Beijing Ruiweixituo Biotechnology Co.,Ltd.'s registered trademark portfolio includes well-known marks such as HERBA MEGA. These are among 1 currently registered trademark in the portfolio.

What is Beijing Ruiweixituo Biotechnology Co.,Ltd.'s trademark registration success rate?

Beijing Ruiweixituo Biotechnology Co.,Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.